In-vivo observations on angiogenesis in embryonic zebrafish: dose-dependent effects of the prolyl-4-hydroxylase inhibitor, Di-methyl oxalyl-glycine, on arterial development

In-vivo observations on angiogenesis in embryonic zebrafish: dose-dependent effects of the prolyl-4-hydroxylase inhibitor, Di-methyl oxalyl-glycine, on arterial development

Opis bibliograficzny
Główni autorzy:	Kelly, D, Mecinovic, J, Schofield, C, Crossman, D, Ingham, P, Gershlick, A, Chico, T
Format:	Journal article
Wydane:	2008

Podobne zapisy

In-vivo observations on angiogenesis: Dose-dependent effects of the prolyl-4-hydroxylase inhibitor, di-methyl oxalyl-glycine, on arterial development in embryonic zebrafish
od: Kelly, D, i wsp.
Wydane: (2008)

UPREGULATION OF HYPDXIA-INDUCIBLE FACTOR 1 alpha BY DI-METHYL OXALYL GLYCINE PROMOTES ANGIOGENESIS WITHIN ISCHAEMIC MYOCARDIUM IN A PORCINE CORONARY OCCLUSION MODEL
od: Kelly, D, i wsp.
Wydane: (2010)

74 Pro-Angiogenic Effects of the Prolyl-hydroxylase Inhibitor FG-2216/BIQ: Therapeutic Angiogenesis for the Treatment of Chronic Total Occlusions.
od: Barnett, G, i wsp.
Wydane: (2014)

Mass spectrometric studies on an oxygen sensing prolyl hydroxylase
od: Mecinovic, J, i wsp.
Wydane: (2007)

2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.
od: Mecinović, J, i wsp.
Wydane: (2009)

BIOL 56-ESI-MS studies on prolyl hydroxylase domain 2
od: Mecinovic, J, i wsp.
Wydane: (2008)

Prolyl hydroxylases and therapeutics.
od: Smith, T, i wsp.
Wydane: (2010)

Inhibition of a viral prolyl hydroxylase
od: Langley, G, i wsp.
Wydane: (2019)

Use of mass spectrometry to probe the nucleophilicity of cysteinyl residues of prolyl hydroxylase domain 2.
od: Mecinović, J, i wsp.
Wydane: (2009)

Regulation of HIF: prolyl hydroxylases.
od: Stolze, I, i wsp.
Wydane: (2006)

Substrate selectivity of prolyl hydroxylases
od: McDonough, M
Wydane: (2018)

Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
od: Chowdhury, R, i wsp.
Wydane: (2009)

Exploring the substrate selectivity of oxygen sensing prolyl hydroxylases
od: Lippl, K, i wsp.
Wydane: (2015)

Structural and mechanistic studies on prolyl hydroxylases
od: Chowdhury, R
Wydane: (2008)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
od: Mole, D, i wsp.
Wydane: (2003)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
od: Figg, WD, i wsp.
Wydane: (2021)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
od: McNeill, L, i wsp.
Wydane: (2002)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
od: Schlemminger, I, i wsp.
Wydane: (2003)

ESI-MS studies on prolyl hydroxylase domain 2 reveal a new metal binding site.
od: Mecinović, J, i wsp.
Wydane: (2008)

Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
od: Hewitson, K, i wsp.
Wydane: (2007)

Iron homeostasis and its interaction with prolyl hydroxylases.
od: Mole, D
Wydane: (2010)

Structural, functional and evolutionary studies on prolyl-hydroxylases
od: Scotti, J
Wydane: (2014)

Small-molecules that covalently react with a human prolyl hydroxylase – towards activity modulation and substrate capture
od: Bush, J, i wsp.
Wydane: (2018)

The Prolyl Hydroxylase Inhibitor BIQ/FG-2216 Stabilises HIF-1 alpha and Upregulates VEGF in vitro: A Potential Strategy For Difficult CTO Lesions in Patients.
od: Barnett, G, i wsp.
Wydane: (2013)

2-oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2
od: Abboud, M, i wsp.
Wydane: (2018)

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)
od: Chowdhury, R, i wsp.
Wydane: (2011)

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).
od: Chowdhury, R, i wsp.
Wydane: (2011)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
od: Richardson, NL, i wsp.
Wydane: (2021)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
od: Holt-Martyn, J, i wsp.
Wydane: (2019)

Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma
od: Atkinson, Aithne, i wsp.
Wydane: (2020)

Collagen Prolyl 4-Hydroxylase as a Therapeutic Target
od: Vasta, James D., i wsp.
Wydane: (2020)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
od: Tuckerman, JR, i wsp.
Wydane: (2004)

Mechanistic studies on human prolyl hydroxylase domain 2
od: Fiorini, G
Wydane: (2024)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase, and is sensitive to off target inhibition by prolyl hydroxylase domain inhibitors that stabilise Hypoxia Inducible Factor
od: Kiriakidis, S, i wsp.
Wydane: (2017)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
od: Yeoh, K, i wsp.
Wydane: (2013)

Increased endothelial cell mobility following stabilization of hypoxia-inducible factor-steps towards therapeutic angiogenesis
od: Kelly, D, i wsp.
Wydane: (2008)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
od: Chan, M, i wsp.
Wydane: (2016)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
od: Chowdhury, R, i wsp.
Wydane: (2016)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
od: Flashman, E, i wsp.
Wydane: (2010)

Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
od: Flashman, E, i wsp.
Wydane: (2010)